Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: res (Q45236772)
Jump to navigation
Jump to search
scientific article published on 24 January 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: res |
scientific article published on 24 January 2005 |
Statements
Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG) (English)
Martin Dreyling
Georg Lenz
Bernhard Wörmann
Ulrich Dührsen
Bernd Metzner
Hartmut Eimermacher
Andreas Neubauer
Hannes Wandt
Hjalmar Steinhauer
Sonja Martin
Else Heidemann
Ali Aldaoud
Reza Parwaresch
Joerg Hasford
Wolfgang Hiddemann
24 January 2005